4 Healthcare Stock Stories Not To Be Overlooked

AstraZeneca Group (NYSE:AZN): Closing price $46.18

The firm is poised to slash approximatey 1,600 jobs as it reconfigures its research operations and consolidates drug development work in three major centers in the United Kingdom, the United States and Sweden. The phase will see the cessation of drug development at the company’s Alderley Park facility in northwest England, which for many years markied a hub of the group’s research and development efforts, according to the drugmaker on Monday.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.